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Abstract 
 
Quantitative measurement of cerebral blood flow using QUIPSS II pulsed arterial spin 
labeling relies on the assumption that the time between label and QUIPSS saturation is shorter 
than the natural temporal bolus width. Yet, the duration of the bolus of tagged blood spins 
entering the region of interest may vary across subjects due to physiological differences in 
blood velocity or vessel geometry. We present a new technique, Bolus Turbo Sampling 
(BoTuS), to rapidly measure the duration of the inflowing bolus. This allows optimizing the 
ASL acquisition for each subject to ensure reliable quantification of perfusion while 
maximizing SNR by avoiding the use of unnecessarily short label durations. The repeatability 
of this technique is evaluated and its validity assessed by comparison with ASL data acquired 
at variable TI1 and by testing subjects at different physiologic states. 
 
  
Introduction   
 
Arterial Spin Labeling (ASL) is a quantitative MRI method to non-invasively measure 
cerebral blood flow (CBF)[1]. The longitudinal magnetization of water spins in arterial blood 
is inverted in the feedings arteries and subsequently the flowing tagged spins are imaged in 
the region of interest after a certain delay (TI2). ASL methods can be divided into continuous 
and pulsed ASL (PASL) techniques depending on the way spins are tagged. PASL is widely 
used in clinical research protocols due to its ease of implementation, its lower specific 
absorption rate (SAR) and the absence of need for specific coils. The ASL signal depends not 
only on CBF but also on factors such as magnetization at equilibrium, tagging efficiency, 
temporal width of the bolus of tagged spins () and the transit time of blood from the label 
slab to the imaging slice[2]. The QUIPSSII[3] and Q2TIPS[4] sequences aim to eliminate 
sensitivity to bolus duration and transit times by saturating the longitudinal magnetization of 
labeled spins remaining in the label region after a delay TI1. This delay, if shorter than the 
natural bolus duration, defines the temporal width of the bolus. However, if the saturation is 
applied too late, the actual temporal width of the bolus is shorter than TI1, leading to errors in 
the quantification of CBF from the ASL signal[5].  
One response to this issue are multi-TI ASL techniques like QUASAR[6] or Bolus-tracking 
ASL[7]. Since images are acquired at different inversion times, transit delay and bolus 
duration can be obtained and accounted for by fitting model functions to the ASL signal. 
However, multi-TI acquisitions require significantly longer acquisition times or limit the 
spatial coverage available, and require more sophisticated analysis techniques to obtain robust 
CBF maps. 
Previous single-TI studies have tried to use optimal values for the saturation delay TI1, fixed 
for all subjects in a study. However, its dependence on patient population, geometrical label 
width and position of the label pulse implies that this optimization may need to be performed 
for each specific study[8]. Furthermore, if quantitative CBF measurements are to be 
guaranteed, the shortest natural bolus duration occurring in the patient population dictates the 
choice of the TI1 for all subjects, leading to a loss in sensitivity in subjects with longer label 
durations. 
The aim of this study is to validate a new technique (BoTuS, for Bolus Turbo Sampling) to 
measure the natural bolus duration  in each subject and thus to optimize the TI1 parameter 
individually[9], [10]. This technique directly traces the bolus of the tagged spins for about 
three seconds after the application of the tag pulse, with a temporal resolution of fifty 
milliseconds. The initial shape of the bolus of the tagged spins is modeled as a boxcar 
function with flow through the vasculature modeled as a Gaussian dispersion of the tag in 




For this study, a total of thirteen healthy volunteers (age 23-40 years, five female) were 
scanned on a 3-T Philips Achieva TX whole body scanner using whole-body RF transmit and 
8-channel head receive coils. The institutional review board approved the protocol and all 
subjects gave prior written consent to participate in the study. During all acquisitions we 
recorded physiological parameters of our subjects (EtCO2, SpO2, respiratory frequency, heart 
rate) to verify that the subjects stayed in the same physiological state. The entire protocol 
consisted of two parts: 1) the measurement of the shape of the bolus using the BoTuS 
technique, performed twice under baseline physiologic conditions, once at the beginning and 
once towards the end of each session in order to assess repeatability, and performed once 
during globally increased CBF under hypercapnia at the end of the session 2) a different 
measurement of the natural duration of the bolus from multi-TI1 data, to obtain an 




The purpose of this part of the study was to assess the feasibility and the repeatability of the 
BoTuS technique. The aim of this sequence is to rapidly measure the bolus shape of the 
tagged spins entering our region of interest (ROI). The BoTuS sequence consists of a 
PICORE[3] tagging scheme (tag width=200 mm, label gap=15 mm) immediately followed by 
a rapidly repeated EPI read-out on one axial slice just above the Circle of Willis scanned 
every 50 ms until TI=2900 ms (Figure 1a). Acquisition parameters were: flip angle=90°, 
TE=19 ms, EPI BW=3525 Hz, voxel size=4*4*5 mm, NA=10 ctl-tag pairs, total scan 
duration=1’18”. The 90° flip angle assures that the signal is dominated by fresh spins entering 
the slice between consecutive acquisitions. At a TR of 50 ms in a 5-mm slice, blood in the 
arteries crossing the slice is fully replaced at flow speeds above 10 cm/s. This is long enough 
to be sure that fresh blood arrives between subsequent EPI acquisitions in the major feeding 
arteries of the brain (VPCA > 20cm/s[14]). The mean difference image from the 10 control-tag 
pairs shows the inflowing bolus in large vessels at each TI. During the protocol we acquired a 
total of three BoTuS datasets. Two were acquired at baseline physiologic conditions separated 
by 40 min to test for repeatability. We also tested the capacity of the BoTuS sequence to 
detect the global flow differences after a vasodilator paradigm using increased fiCO2 (8% 
CO2, 21% O2, balance N2 administered at approximately 12 l/min via a non-rebreathing face 
mask). We acquired the hypercapnia BoTuS dataset during CO2 inhalation, shortly after the 
second baseline BoTuS dataset.  
MATLAB® (The Mathworks, Inc., Natick, MA, USA) was used for the post-processing of the 
data. The mean difference between control and tag images was calculated to obtain a vascular 
ASL signal map at each TI. Using the Brain Extraction Tool (bet2) from FSL[15] data from 
non-brain tissue were eliminated. To automatically select voxels with arterial signal, four 
large regions approximately corresponding to anterior cerebral artery (ACA), posterior 
cerebral artery (PCA), and left and right middle cerebral artery (MCA) vascular territories 
were defined (Figure 1b). The area under the bolus curve (AUC) was computed for each 
voxel and voxels with at least 20% of the maximal AUC in each territory were selected. The 
cluster of connected voxels with the highest cumulative AUC in each of the four vascular 
territories was retained as ROI for the subsequent analysis. We fitted the bolus in each voxel 
from each ROI with the model of Ozyurt [I] based on a modified version of Hrabe-Lewis 
model to account for the dispersion of the labeled bolus[11] (Figure 1c):  
 
[I]   
 
where A is an amplitude factor, T1B is the T1 of the arterial blood,  is the natural width of the 
bolus of tagged spins, t is the transit delay between label region and imaging slice and k is 
the dispersion constant. A four-parameter fit was performed using the Levenberg-Marquardt 
algorithm[16], adjusting A, , t and k on a per-voxel basis. 
After averaging the model curves from each voxel of the ROIs, we extracted the full width at 
half-maximum from the average bolus model curve, taking into account the T1 decay 
(Figure 1c). We thus obtain a value of the bolus width for each of the four ROIs from each 
BoTuS dataset. 
 
Multi-TI1 ASL protocol  
 
In order to independently measure the duration of the bolus of labeled blood, we measured 
and analyzed the ASL signal as a function of TI1, at constant TI2. The ASL signal in a 
QUIPSS II sequence is directly proportional to the quantity of labeled blood that leaves the 
label region prior to TI1. Blood flow can be assumed to be constant during the TI1 period, if 
signals are averaged over many repetitions that are not synchronized to cardiac phase[17]. If 
TI1 is shorter than or equal to the natural duration of the bolus, the ASL signal increases 
linearly as a function of TI1. For longer TI1 delays, the ASL signal is independent of TI1, as 
all labeled blood has left the label region prior to the saturation pulse. This provides an 
independent means of measuring the natural duration of the bolus of labeled spins. More 
standard multi-TI2 ASL signal measurements also provide information about the label width, 
but they depend in addition on transit delay, which makes the data less robust to analyze. 
We acquired a series of 12 PASL datasets varying the TI1 from 200 ms to 1300 ms in 100 ms 
increments in a Q2TIPS sequence in randomized order. ASL acquisition parameters were: 
EPI single shot images, voxel size [4-4-5 mm], 14 slices, 30 pairs of images, tag 
width=200 mm, label gap=15 mm, TE=24 ms, total acquisition time ~40 min. The minimum 
TI2 was fixed to 1800 ms. TR and TI2 were mostly independent of TI1, but needed to be 
adapted for the shortest and longest TI1-values due to sequence timing constraints. The exact 
parameter values used are listed in Table 1. For subjects 11-13 we added measurement points 
at TI1= 1600 and 2000 ms and used a SENSE factor 2.5 with a TE of 19 ms. The first slice of 
the ASL acquisitions is the same as the BoTuS slice (Figure 2a). We acquired a high-
resolution T1-weighted structural image to obtain grey and white matter masks using SPM8 
(3D GRE TR=8.1 ms, TE=3.8 ms. voxel size [1-1-1.3 mm], 256 mm field of view, 100 
contiguous sagittal slices).  
All images were realigned, coregistered to the anatomic image and normalized to the MNI 
ICBM atlas using SPM8 software (SPM, Wellcome Department of Imaging Neuroscience, 
http://www.fil.ion.u-cl.ac.uk/spm/). Control and label images were subtracted. Data acquired 
at a TI2 different from 1800 ms were corrected for T1-decay assuming an arterial blood T1 of 
1700 ms[18]. We calculated the average ASL data from the grey matter in MCA, ACA and 
PCA territories, for each of the 12 acquisitions (Figure 2b). We then plotted the ASL signal as 
a function of the TI1 and fitted it with the model of Ozyurt integrated over time. To determine 
TI1,max, the highest TI1 acceptable for ASL data acquisition according to the multi-TI1 data, 
we located the point beyond which the model curve was outside a 10% margin around the 
initial linear slope (Figure 2c). 
 




The acquisition time of the BoTuS sequence is 78 seconds. Subsequently, about 2 minutes of 
processing are required to obtain the bolus width in the four vascular territories. From the 104 
measurements we made under baseline physiologic conditions, 12 were excluded due to an 
insufficient quality of fit (R2<0.9). Capnia remained constant throughout all acquisitions 
under baseline condition. 
The differences between the bolus width in the left and right MCA and the ACA for our 13 
subjects are not statistically significant (right MCA=(708±121) ms; left MCA=(743±116) ms; 
ACA=(811±156) ms - mean±std), with a higher inter-individual variability in the ACA 
territory. However, we measured significantly longer bolus duration in the PCA territory: 
(1094±211) ms. The mean bolus widths for right and left MCA territories for each subject are 
spread from 550 ms to 977 ms.  
We tested the repeatability of the technique by measuring the bolus shape twice, at an interval 
of 40 minutes. The repeatability is good as shown in the Bland-Altmann[19] scatter-plot (Fig 
3). One subject out of thirteen showed a difference to mean exceeding the 2-interval. The 
mean difference between the two measurements is significantly different from zero, which 
implies the presence of an order-effect. 
The repeatability coefficient[19] for the measurement of the average bolus width in the right 
and left MCA territories is 75 ms, that is, the absolute difference between two repeated 
measurements is expected to be smaller than this value in 95% of the cases. With a mean 
bolus width of 728 ms in right and left MCA territories for our 26 measurements, this 
represents a difference of 10% between two measurements on the same subject. The 
minimum of the bolus widths in left and right MCA territories (instead of their average) 
showed the same repeatability. 
The mean MCA bolus width in 12 subjects (1 subject was excluded due to an insufficient 
quality of fit (R2<0.9)) was (498±176) ms under hypercapnia (HC) and (747±113) ms under 
normocapnia (NC) immediately prior to the HC experiment. The analyses of the physiological 
parameters of our subjects showed no significant difference before and during HC in heart 
rate (NC=(61±7) min-1 ; HC=(62±7) min-1), arterial oxygen saturation (NC=(98±1)% ; 
HC=(98±1)%) and respiratory rate (NC=(15±3) min-1 ; HC=(15±3) min-1). The mean end-
tidal CO2 increased from (46±6) mmHg during normocapnia to (57±6) mmHg under 
hypercapnia. If we assume that the observed reduction in bolus width is inversely proportional 
to the perfusion change then the mean increase in perfusion due to the CO2 paradigm was 
(6±4.3) %/mmHg which is consistent with the literature[20]. The responses to this stimulus 
were however very heterogeneous between subjects. 
 
Multi-TI1 ASL protocol 
 Five subjects were excluded due to excessive motion or because the quality of the fit was bad 
due to a poor signal to noise ratio (R2<0.9). The mean TI1,max on the remaining 8 subjects is 
(1020±182) ms for the right and left MCA territories, (1009±250) ms for the ACA territory 
and (1152±435) ms in the PCA territory. The differences between the three territories are not 
significant. Also the values in the PCA territories are very heterogeneous and calculated on 
two subjects only since the others showed a R2 lower than 0.9.  
 
Correlation between BoTuS results and multi-TI1 data  
 
We saw a significant correlation between the bolus width measured in the MCA territory 
using BoTuS method and the TI1,max determined from multi-TI1 data, with a Pearson 
coefficient of 0.65 (p<0.05) (Figure 4a). The bolus width derived from the pre-scan under-




The rapid bolus shape pre-scan (acquisition time of 1’18”) allowed determining an optimized 
TI1 for each subject. The pre-scan acquisition time is dramatically reduced compared to the 40 
minutes of acquisitions needed to obtain the bolus width using the 12 PASL multi-TI1 data 
points. There are significant differences in the measured bolus widths between vascular 
territories. Indeed, the PCA are predominantly fed by the basilar arteries, which exhibit 
slower flow than the ICA predominantly feeding the MCA[21]. This slower velocity 
generates a longer bolus. The higher inter-individual variability that we observed on the ACA 
territories is certainly due to the heterogeneities of the ROI in that region. The right and left 
MCA territories are the most homogeneous regions since we selected the middle cerebral 
arteries just above the circle of Willis. The repeatability of the BoTuS technique in this 
territory is good as shown in the Figure 3.  
The estimation of the allowable TI1 from the multi-TI1-data is taken as a reference since it 
directly samples the ASL signal of interest. However, it suffers from low SNR. The long 
acquisition times make the results prone to motion artifacts and prevented us from assessing 
its repeatability. Almost 40% of the multi-TI1-data had to be discarded. To somewhat 
alleviate the problem of SNR, and because the bolus duration is shorter in this territory, we 
used the large MCA territories (2400 voxels on average) to examine the correlation with the 
BoTuS method. The results in the ACA and PCA territories are more variable due to the small 
ROIs, given the position of the imaging volume above the circle of Willis (950 and 
290 voxels, respectively).  
The significant correlation between the BoTuS and the multi-TI1 methods indicates that our 
BoTuS sequence has the potential for optimizing PASL acquisitions. However, the BoTuS 
results are not immediately comparable to the multi-TI1 data, since the TI1,max is a measure of 
the integral under the bolus curve. A calibration is therefore necessary to translate the width at 
half maximum of the roi-average bolus model to a subject-optimized TI1. The limited multi-
TI1 data available in this study leads us to an empirical calibration: 
TI1,sequence=1,2*TI1,BoTuS,MCA (Figure 4b). 
The bolus widths measured by multi-TI1 PASL in the MCA territory with a 200-mm label 
region vary from 717 ms to 1226 ms. With the choice of a fixed TI1 of 700 ms, perfusion 
would be quantified accurately for all of our subjects under baseline physiologic conditions. If 
we determine a per-subject TI1 using the rapid BoTuS pre-scan and our calibration, one 
BoTuS scan in one subject may suffer from under-estimation of the perfusion by about 11%. 
On the other hand, with TI2=1800 ms, the optimized TI1 would lead to an average gain of 
18% in ASL signal, with respect to the fixed TI1 of 700 ms. 
The ASL literature is relatively sparse in data concerning the optimal choice of TI1 depending 
on label width, position, and subject population. From the limited data presented here it is 
obvious that inter-subject heterogeneity in label duration is large. The method presented has 
the potential to avoid the need for time-consuming optimizations of this parameter, and to 
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Tables and Figures 
TI1 (ms) 200 300 400 500 600 700 800 900 1000 1100 1200 1300 1600 2000 
TI2 (ms) 1800 1800 1800 1800 1800 1800 1800 1800 1800 1900 2100 2100 2300 2700 
TI (ms) 1600 1500 1400 1300 1200 1100 1000 900 800 800 900 800 700 700 
TR (ms) 3500 3400 3300 3200 3100 3000 3000 3000 3000 3000 3100 3000 3000 3400 
  
Table 1. Acquisition parameters of multi-TI1 images  (TI1: Time between label 
and QUIPSS saturation, TI2: time between label and acquisition of the first slice, 
TI=time between saturation and acquisition (TI1+TI=TI2), TR: time between 




Figure1: a) Position of the BoTuS acquisition slice just above the circle of 
Willis, b) ROIs of connected voxels with strong vascular signal in right and left 
middle cerebral arteries, and in the anterior and posterior area, c) Normalized 
control/tag difference from the BoTuS sequence showing the bolus shape of the 
tagged spins entering our regions of interest for four vascular territories. The 
dashed line indicates the cutoff at half the peak amplitude after correction for 




Figure 2: a) Position of the multi-TI1 imaging slices. The first slice of the PASL 
region of interest is the same as the BoTuS slice, b) Vascular territory map 
(pink: middle cerebral arteries, blue: anterior cerebral arteries, purple: posterior 
cerebral arteries), c) Average ASL signal in the gray matter of the MCA 
territories as a function of TI1 for a single subject. The solid line represents the 
fit to the data and the shaded region indicates the limits of the linear regime of 
the ASL signal. 
 
  
Figure 3: Repeatability of the BoTuS results shown in a Bland-Altmann graph 
representing the difference to the mean for two separate measurements as a 
function of their mean. 
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Figure 4: a) Correlation between the bolus width measured twice using BoTuS 
and using multi-TI1 PASL for 8 subjects with linear correlation and unity line, b) 
Correlation between the bolus width measured using BoTuS after correction 
(TI1,sequence=1,2 * TI1,BoTuS ) and multi-TI1 PASL method for 8 subjects. 
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